Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.
2.

Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.

Watari H, Hosaka M, Mitamura T, Moriwaki M, Ohba Y, Todo Y, Takeda M, Ebina Y, Sakuragi N.

Eur J Gynaecol Oncol. 2008;29(6):573-7.

PMID:
19115681
3.

Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.

Morgan RJ Jr, Braly P, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Najera L, Johnson D, Doroshow JH.

Gynecol Oncol. 2000 Jun;77(3):433-8.

PMID:
10831355
5.

Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.

Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.

Cancer. 1996 Jul 15;78(2):211-6.

6.

5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma.

Reed E, Jacob J, Ozols RF, Young RC, Allegra C.

Gynecol Oncol. 1992 Sep;46(3):326-9.

PMID:
1526510
7.

The use of Fluorouracil (5-FU) and leucovorin in women with heavily pretreated advanced ovarian carcinoma.

Peled Y, Levavi H, Krissi H, Weill Y, Sabah G, Eitan R.

Am J Clin Oncol. 2013 Oct;36(5):472-4. doi: 10.1097/COC.0b013e3182549399.

PMID:
22706176
8.

Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.

Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.

Cancer. 2001 Jun 15;91(12):2288-93.

PMID:
11413517
9.

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.

Kaltsas GA, Mukherjee JJ, Isidori A, Kola B, Plowman PN, Monson JP, Grossman AB, Besser GM.

Clin Endocrinol (Oxf). 2002 Aug;57(2):169-83. Review.

PMID:
12153595
10.
11.

[Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].

Israël L, Lepage E, Breau JL, Aguilera J.

Bull Cancer. 1982;69(5):426-33. French.

PMID:
6891902
12.

Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.

Pectasides D, Pectasides M, Farmakis D, Gaglia A, Koumarianou A, Nikolaou M, Koumpou M, Kountourakis P, Papaxoinis G, Mitrou P, Economopoulos T, Raptis SA.

Gynecol Oncol. 2004 Oct;95(1):165-72.

PMID:
15385127
14.

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.

Meropol NJ, Niedzwiecki D, Hollis D, Schilsky RL, Mayer RJ; Cancer and Leukemia Group B.

Cancer. 2001 Apr 1;91(7):1256-63.

PMID:
11283924
15.

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.

Chau I, Webb A, Cunningham D, Hill M, Waters JS, Norman A, Massey A.

Br J Cancer. 2001 Nov 2;85(9):1258-64.

16.

Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.

Scheithauer W, Depisch D, Kornek G, Pidlich J, Rosen H, Karall M, Prochaska M, Ernst A, Sebesta C, Eckhardt S.

Cancer. 1994 Mar 15;73(6):1562-8.

17.

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy.

Sundar S, Symonds RP, Decatris MP, Kumar DM, Osman A, Vasanthan S, O'byrne KJ.

Gynecol Oncol. 2004 Aug;94(2):502-8.

PMID:
15297195
18.

First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.

Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.

J Infus Chemother. 1996 Summer;6(3):149-51.

PMID:
9229328
19.

[Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].

de Gramont A, Drolet Y, Louvet C, Dray C, Krulik M, Pigné A, Lavoie A, Painchaud M, Blouin R, Tessier C, et al.

J Gynecol Obstet Biol Reprod (Paris). 1986;15(1):105-9. French.

PMID:
3084619
20.

Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.

Pujade-Lauraine E, Guastalla JP, Weber B, Curé H, Orfeuvre H, Mousseau M, Vincent P, Diéras V, Tubiana-Mathieu N, Jacquin JP, Mignot L, Leduc B, Paraïso D, Viens P.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-30-S15-35.

PMID:
9346219

Supplemental Content

Support Center